Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the ...

The Gift Nifty futures were trading at 23,622 as of 08:18 a.m. IST, indicating that the benchmark Nifty 50 will open slightly ...

Drug maker Cipla on Wednesday said the US health regulator has issued eight observations after inspecting its Bengaluru-based ...

Cipla Ltd. announced on Wednesday that the company received eight observations from the US Food and Drug Administration for ...

NSE's Nifty50 tumbled 324.40 points, or 1.36 per cent, to close at 23,559.05 for the day. Some buzzing pharma stocks ...

Shivam Puri, CEO, Cipla Health, discusses the brand proposition of Prolyte ORS, shares strategy that helped brand achieve Rs ...

The development reflects the company's strategy to raise funds and expand its market position. CIPLA Cipla is in focus due to ...

Stay informed with the Cipla Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a ...

Cipla , India's third-largest generic drugmaker by sales, reported a 15.2% rise in second-quarter profit that beat estimates, ...

Following an inspection of its Bengaluru facility, Cipla has received 8 observations in Form 483 from the US Food and Drug ...

Here's the complete list of investment and trading ideas for the day. Buy Garden Reach shares in the cash segment for a ...

The US Food and Drugs Administration (USFDA) conducted an inspection at the company's manufacturing facility in Virgonagar, ...